Iguana Healthcare Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Iguana Healthcare Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$2.38M	Sell	125,000 -25,000	-17%	-$534K	1.56%	26
2017 Q4	$2.46M	Sell	150,000 -50,000	-25%	-$744K	1.6%	22
2017 Q3	$3M	Sell	200,000 -15,000	-7%	-$166K	1.63%	27
2017 Q2	$1.89M	Buy	215,000 +65,000	+43%	+$417K	1.07%	38
2017 Q1	$780K	Buy	+150,000	New	+$602K	0.39%	62
2016 Q3	–	Sell	-125,000	Closed	-$724K	–	98
2016 Q2	$724K	Buy	125,000 +50,000	+67%	+$319K	0.29%	70
2016 Q1	$454K	Sell	75,000 -125,000	-63%	-$751K	0.17%	72
2015 Q4	$1.83M	Buy	+200,000	New	+$1.54M	0.6%	48

Other funds holding SGMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Iguana Healthcare Management's SGMO Position: Q1 2018 in Review

Iguana Healthcare Management reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 17% in Q1 2018, selling an estimated $534K and leaving 125,000 shares worth $2.38M. The position accounts for 1.56% of the portfolio, ranked #26.

Iguana Healthcare Management first reported a position in SGMO in Q4 2015 and has held it in 8 quarters since. The position peaked at $3M in Q3 2017. 208 funds tracked by Wall St. Rank hold SGMO as of Q1 2018.

Iguana Healthcare Management held 125,000 shares of SANGAMO THERAPEUTICS INC worth $2.38M as of Q1 2018.
Iguana Healthcare Management sold 25,000 SANGAMO THERAPEUTICS INC shares in Q1 2018, an estimated $534K.
SANGAMO THERAPEUTICS INC made up 1.56% of Iguana Healthcare Management's portfolio in Q1 2018, its #26 holding.
Iguana Healthcare Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2015 and has held it in 8 quarters since.
Iguana Healthcare Management's SANGAMO THERAPEUTICS INC position peaked at $3M in Q3 2017.
208 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.